Country: Spain
Language: English
Source: HMA (Heads of Medicines Agencies)
phenobarbital 15 mg
Desitin Arzneimittel GmbH
QN03AA02
Tablet
Phenobarbital
Dogs Non Food
2010-09-29
Desitin Arzneimittel GmbH Phenobarbital, 15 mg tablets DE/V/0141/001 PART 1B: PRODUCT INFORMATION 06/2013 C O N F I D E N T I A L Page 1/9 1.B.1 SUMMARY OF PRODUCT CHARACTERISTICS _Phenobarbital _ _15 mg _ _tablets _ Desitin Arzneimittel GmbH Phenobarbital, 15 mg tablets DE/V/0141/001 PART 1B: PRODUCT INFORMATION 06/2013 C O N F I D E N T I A L Page 2/9 1. NAME OF THE VETERINARY MEDICINAL PRODUCT (DE) Luminaletten vet, 15 mg tablets for dogs (AT, BE, DK, ES, FR, NL, PT, SE) Epirepress 15 mg, tablets for dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: ACTIVE SUBSTANCE: Phenobarbital 15 mg EXCIPIENTS: For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Tablet White, round, slightly domed tablets, diameter 5.7 mm, with TC imprinted on one side and a breakline on the other side. The tablets cannot be divided into equal halves. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dog 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Prevention of seizures due to generalised epilepsy in dogs. 4.3 CONTRAINDICATIONS Do not use in the case of hypersensitivity to the active substance or to any other barbiturates or to any of the excipients. Do not use in animals with severe impaired hepatic function. Do not use in animals with serious renal and/or cardiovascular/respiratory disorders. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES The decision to start antiepileptic drug therapy with phenobarbital should be evaluated for each individual case and depends on number, frequency, duration and severity of seizures in dogs. Read the complete document